Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastroenterol. Jun 21, 2025; 31(23): 106261
Published online Jun 21, 2025. doi: 10.3748/wjg.v31.i23.106261
Table 2 Peri-operative clinical outcomes, n (%)

ESD (n = 15)
STER (n = 10)
LWR (n = 25)
P value
En bloc resection15 (100.0)10 (100.0)25 (100.0)1.000
Macroscopic complete resection115 (100.0)10 (100.0)25 (100.0)1.000
Microscopic complete resection20.021
    R0 resection13 (86.7)6 (60.0)24 (96)
    R1 resection2 (13.3)4 (40.0)1 (4.0)
Pathological diagnosis< 0.001
    Leiomyoma10 (66.7)9 (90.0)8 (32.0)
    GIST with low-risk33 (20.0)0 (0.0)0 (0.0)
    GIST with intermediate to high-risk42 (13.3)1 (10.0)17 (68.0)
Total procedure time, minutes, median (IQR)75.0 (65.0-100.0)84.0 (73.0-92.0)70.0 (55.0-80.0)0.075
Hospital stay, days, median (IQR)6.0 (5.0-7.0)6.0 (6.0-9.0)5.0 (4.0-6.0)0.017
Fasting duration, days, median (IQR)2.0 (2.0-5.0)3.0 (3.0-4.0)1.0 (1.0-1.0)< 0.001
Long diameter of tumor in pathology, mm, median (IQR)27.0 (15.5-35.0)28.5 (25.0-45.0)36.0 (27.0-45.0)0.002
Complications
    Delayed bleeding2 (13.3)0 (0.0)1 (4.0)0.325
    Pneumoperitoneum52 (13.3)0 (0.0)1 (4.0)0.325
    Peritonitis0 (0.0)0 (0.0)0 (0.0)1.000